Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Debra S Harris"'
Autor:
Peyton Jacob, E. Thomas Everhart, Debra S Harris, R. P. Nath, Reese T. Jones, E. Fernandez, Naoto Uemura, John Mendelson
Publikováno v:
Clinical Pharmacology & Therapeutics. 80:403-420
Objective To help predict the consequences of precursor regulation, we compared the pharmacokinetics and pharmacodynamics of the methamphetamine (INN, metamfetamine) stereoisomers. Methods In this study 12 methamphetamine abusers received intravenous
Autor:
Debra S Harris, Robert M. Anthenelli
Publikováno v:
Current Psychiatry Reports. 7:344-351
Nicotine dependence is the leading preventable cause of adult morbidity and mortality in the world. New research on the treatment of this disorder ranges from studies evaluating access to treatment to studies elucidating the molecular mechanisms of n
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 29:669-677
Decreasing response to stress has been one goal of interventions aimed at reducing relapse to substances of abuse. A laboratory stress test that can be repeated would be helpful in testing the efficacy of interventions in decreasing the response to s
Publikováno v:
The American Journal of Drug and Alcohol Abuse. 30:765-782
Preclinical data suggest a link between stress reactivity and cocaine self-administration by rodents. Serotonin appears to modulate the hypothalamic-pituitary-adrenal (HPA) axis. We studied the effects of chronic treatment with the serotonin reuptake
Autor:
John Mendelson, Debra S Harris, E. Thomas Everhart, Gina Sequeira, Harold G. Boxenbaum, Reese T. Jones
Publikováno v:
Clinical Pharmacology & Therapeutics. 74:475-486
Background Patients in harm-reduction treatment programs are switching from intravenous to other routes of methamphetamine (INN, metamfetamine) administration to avoid risks associated with needle use. Relatively little has been reported about the bi
Publikováno v:
Psychopharmacology. 162:396-405
3,4-Methylenedioxymethamphetamine (MDMA) is a widely used phenethylamine. Reports have described the effects of MDMA in a controlled laboratory setting, but the full range of effects of MDMA in humans is still not completely characterized.To describe
Autor:
Anne L. Hoff, Laura Marsh, Debra S Harris, Adolf Pfefferbaum, Michael Beal, Judith M. Ford, William O. Faustman, Daniel H. Mathalon
Publikováno v:
Biological Psychiatry. 46:94-101
Background: Relationships between illness severity and neurobiologic abnormalities in schizophrenia were studied in subpopulations varying in clinical severity. Methods: Auditory ERPs were collected from 28 severely ill, chronically hospitalized schi
Autor:
John G. Csernansky, Michael Beal, Laura Marsh, Kelvin O. Lim, Kyungtak Minn, Debra S Harris, Adolf Pfefferbaum, Edith V. Sullivan, Anne L. Hoff, William O. Faustman
Publikováno v:
Biological Psychiatry. 45:49-61
Background: The relationship between illness severity and neuroanatomical abnormalities in schizophrenia remains unclear. The purpose of this study was to test whether the pattern and extent of brain volume abnormalities differed between two patient
Autor:
Laura Marsh, Debra S Harris, John G. Csernansky, Edith V. Sullivan, Michael Beal, Anne L. Hoff, Kelvin O. Lim, Kyungtak Minn, William O. Faustman, Adolf Pfefferbaum
Publikováno v:
Biological Psychiatry. 40:4-13
This study examined whether the degree of brain dysmorphology observable in adulthood was related to onset age of schizophrenic symptoms. Brain magnetic resonance imaging (MRI) scans were acquired in 57 men with schizophrenia, whose age at MRI was 19
Autor:
Robert D. Mone, William O. Faustman, James A. Moses, Diana DeVilliers, Michael Beal, John G. Csernansky, Debra S Harris, Anne L. Hoff
Publikováno v:
Schizophrenia Research. 20:21-28
Characterizing a pattern of cognitive dysfunction in early onset schizophrenic patients may illuminate neurodevelopmental contributions to the illness. A cohort of chronically institutionalized schizophrenic patients with a variable range of age of o